MX2010000150A - Derivados de aminoacidos. - Google Patents
Derivados de aminoacidos.Info
- Publication number
- MX2010000150A MX2010000150A MX2010000150A MX2010000150A MX2010000150A MX 2010000150 A MX2010000150 A MX 2010000150A MX 2010000150 A MX2010000150 A MX 2010000150A MX 2010000150 A MX2010000150 A MX 2010000150A MX 2010000150 A MX2010000150 A MX 2010000150A
- Authority
- MX
- Mexico
- Prior art keywords
- hydrogen
- optionally substituted
- amino acid
- group
- nr3r4
- Prior art date
Links
- 150000003862 amino acid derivatives Chemical class 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000006413 ring segment Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- -1 carboxyl ester Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/25—Sulfonic acids having sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0713189.9A GB0713189D0 (en) | 2007-07-06 | 2007-07-06 | Amino acid derivatives |
| PCT/GB2008/002313 WO2009007696A1 (en) | 2007-07-06 | 2008-07-04 | Amino acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010000150A true MX2010000150A (es) | 2010-03-18 |
Family
ID=38440555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010000150A MX2010000150A (es) | 2007-07-06 | 2008-07-04 | Derivados de aminoacidos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8258097B2 (enExample) |
| EP (1) | EP2176217B1 (enExample) |
| JP (1) | JP5422557B2 (enExample) |
| CN (1) | CN101730678B (enExample) |
| AU (1) | AU2008273923B2 (enExample) |
| BR (1) | BRPI0814800A2 (enExample) |
| CA (1) | CA2692608A1 (enExample) |
| GB (1) | GB0713189D0 (enExample) |
| MX (1) | MX2010000150A (enExample) |
| NZ (1) | NZ583075A (enExample) |
| WO (1) | WO2009007696A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6567049B2 (ja) | 2014-10-21 | 2019-08-28 | アッヴィ・インコーポレイテッド | カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法 |
| AU2016258179B2 (en) | 2015-05-06 | 2021-07-01 | Synagile Corporation | Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use |
| AU2016314617A1 (en) * | 2015-09-02 | 2018-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
| EP3749677A1 (en) | 2018-02-08 | 2020-12-16 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd | Dopamine precursors |
| CA3117983A1 (en) | 2018-11-15 | 2020-05-22 | Abbvie Inc. | Pharmaceutical formulations for subcutaneous administration |
| BR112022003974A2 (pt) * | 2019-09-05 | 2022-05-24 | Neuroderm Ltd | Composições líquidas que compreendem um conjugado de aminoácido de levodopa e seus usos |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH562199A5 (enExample) * | 1970-10-30 | 1975-05-30 | Hoffmann La Roche | |
| JPS5422337A (en) | 1977-07-18 | 1979-02-20 | Kyowa Hakko Kogyo Co Ltd | Alphamethyldopa derivatives |
| IT1226727B (it) * | 1988-07-29 | 1991-02-05 | Simes | Farmaci precursori della dopamina. |
-
2007
- 2007-07-06 GB GBGB0713189.9A patent/GB0713189D0/en not_active Ceased
-
2008
- 2008-07-04 WO PCT/GB2008/002313 patent/WO2009007696A1/en not_active Ceased
- 2008-07-04 US US12/667,917 patent/US8258097B2/en not_active Expired - Fee Related
- 2008-07-04 NZ NZ583075A patent/NZ583075A/en not_active IP Right Cessation
- 2008-07-04 EP EP08775861A patent/EP2176217B1/en not_active Not-in-force
- 2008-07-04 AU AU2008273923A patent/AU2008273923B2/en not_active Ceased
- 2008-07-04 CN CN200880023320.1A patent/CN101730678B/zh not_active Expired - Fee Related
- 2008-07-04 CA CA 2692608 patent/CA2692608A1/en not_active Abandoned
- 2008-07-04 MX MX2010000150A patent/MX2010000150A/es active IP Right Grant
- 2008-07-04 BR BRPI0814800-7A2A patent/BRPI0814800A2/pt not_active IP Right Cessation
- 2008-07-04 JP JP2010514127A patent/JP5422557B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009007696A1 (en) | 2009-01-15 |
| US8258097B2 (en) | 2012-09-04 |
| BRPI0814800A2 (pt) | 2015-02-03 |
| EP2176217B1 (en) | 2012-08-22 |
| US20100190725A1 (en) | 2010-07-29 |
| CN101730678B (zh) | 2014-04-02 |
| AU2008273923A1 (en) | 2009-01-15 |
| AU2008273923B2 (en) | 2013-07-11 |
| NZ583075A (en) | 2011-08-26 |
| CN101730678A (zh) | 2010-06-09 |
| EP2176217A1 (en) | 2010-04-21 |
| GB0713189D0 (en) | 2007-08-15 |
| JP2010532751A (ja) | 2010-10-14 |
| CA2692608A1 (en) | 2009-01-15 |
| JP5422557B2 (ja) | 2014-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010000150A (es) | Derivados de aminoacidos. | |
| MY152972A (en) | Azabicyclo compound and salt thereof | |
| NO20082917L (no) | Oksadiazolderivater med CRTH2-reseptoraktivitet | |
| MX2009005219A (es) | Inhibidores macrociclicos del virus de hepatitis c. | |
| MY152153A (en) | Macrocylic inhibitors of hepatitis c virus | |
| PE20090820A1 (es) | Derivados de piperidina/piperazina | |
| AR064459A1 (es) | Derivados de sulfonamida | |
| BR0316146A (pt) | Derivados de amida do ácido 3-(2-hidróxifenil)-1h-pirazol-4-carboxìlico como inibidores de hsp90 para o tratamento de câncer | |
| ES2572155T3 (es) | Compuestos insecticidas | |
| ECSP077422A (es) | Derivado de bencimidazol ariloxi-sustituido | |
| CO5590957A2 (es) | Amino-1,3,5-triazinas sustituidas en n con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas y su uso como herbicidas y reguladores del crecimiento de las plantas | |
| AR067535A1 (es) | Derivados de lactama tetraciclicos | |
| BRPI0407283A (pt) | Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade | |
| UA95972C2 (ru) | Аминопиридиновые производные с селективной ингибирующей активностью в отношении авроры а | |
| AR042423A1 (es) | Diaril eteres como antagonistas del receptor opioide | |
| MY149180A (en) | Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof | |
| PE20090362A1 (es) | Derivados de piperidina/piperazina como moduladores de dgat | |
| NO20071873L (no) | DNA-PK inhibotorer. | |
| AR066972A1 (es) | Derivados azapeptidicos | |
| MX2010008363A (es) | Derivados de arilamida diazepinopirimidona sustituidos para el tratamiento de enfermedades neurodegenerativas causadas por la actividad anormal de gsk3-beta. | |
| TW200639158A (en) | New compounds with therapeutic effect | |
| PE20090548A1 (es) | Compuestos aza-biciclohexano como inhibidores de trombina | |
| ECSP066911A (es) | Polimorfo cristalino de un acetato de bazedoxifeno | |
| SG11201808171PA (en) | Griseofulvin compound | |
| PH12012502027A1 (en) | Plant disease control composition and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |